• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $FTRE

    Fortrea Holdings Inc.

    Subscribe to $FTRE
    $FTRE
    Medical Specialities
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for Fortrea Holdings Inc.

    DatePrice TargetRatingAnalyst
    5/2/2025$7.00Hold
    Truist
    4/10/2025$6.00Equal Weight → Underweight
    Barclays
    12/11/2024$30.00 → $23.00Buy → Neutral
    Citigroup
    12/6/2024$28.00 → $25.00Outperform → Neutral
    Robert W. Baird
    9/25/2024$25.00 → $21.00Buy → Hold
    Jefferies
    8/8/2024$31.00 → $27.00Outperform → In-line
    Evercore ISI
    7/24/2024$30.00Equal Weight
    Barclays
    6/6/2024$28.00Neutral
    Goldman
    5/29/2024$27.00Hold
    TD Cowen
    5/28/2024$27.00Neutral
    Mizuho
    See more ratings

    Fortrea Holdings Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Truist initiated coverage on Fortrea with a new price target

      Truist initiated coverage of Fortrea with a rating of Hold and set a new price target of $7.00

      5/2/25 8:14:26 AM ET
      $FTRE
      Medical Specialities
      Health Care
    • Fortrea downgraded by Barclays with a new price target

      Barclays downgraded Fortrea from Equal Weight to Underweight and set a new price target of $6.00

      4/10/25 8:49:08 AM ET
      $FTRE
      Medical Specialities
      Health Care
    • Fortrea downgraded by Citigroup with a new price target

      Citigroup downgraded Fortrea from Buy to Neutral and set a new price target of $23.00 from $30.00 previously

      12/11/24 7:50:50 AM ET
      $FTRE
      Medical Specialities
      Health Care
    • Fortrea downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded Fortrea from Outperform to Neutral and set a new price target of $25.00 from $28.00 previously

      12/6/24 7:43:22 AM ET
      $FTRE
      Medical Specialities
      Health Care
    • Fortrea downgraded by Jefferies with a new price target

      Jefferies downgraded Fortrea from Buy to Hold and set a new price target of $21.00 from $25.00 previously

      9/25/24 7:38:01 AM ET
      $FTRE
      Medical Specialities
      Health Care
    • Fortrea downgraded by Evercore ISI with a new price target

      Evercore ISI downgraded Fortrea from Outperform to In-line and set a new price target of $27.00 from $31.00 previously

      8/8/24 6:31:41 AM ET
      $FTRE
      Medical Specialities
      Health Care
    • Barclays resumed coverage on Fortrea with a new price target

      Barclays resumed coverage of Fortrea with a rating of Equal Weight and set a new price target of $30.00

      7/24/24 10:28:27 AM ET
      $FTRE
      Medical Specialities
      Health Care
    • Goldman initiated coverage on Fortrea with a new price target

      Goldman initiated coverage of Fortrea with a rating of Neutral and set a new price target of $28.00

      6/6/24 7:15:14 AM ET
      $FTRE
      Medical Specialities
      Health Care
    • TD Cowen initiated coverage on Fortrea with a new price target

      TD Cowen initiated coverage of Fortrea with a rating of Hold and set a new price target of $27.00

      5/29/24 7:31:16 AM ET
      $FTRE
      Medical Specialities
      Health Care
    • Mizuho initiated coverage on Fortrea with a new price target

      Mizuho initiated coverage of Fortrea with a rating of Neutral and set a new price target of $27.00

      5/28/24 7:39:42 AM ET
      $FTRE
      Medical Specialities
      Health Care

    Fortrea Holdings Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • General Counsel Hanson James S. bought $50,600 worth of shares (2,000 units at $25.30), increasing direct ownership by 37% to 7,475 units (SEC Form 4)

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      6/12/24 6:28:42 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • Pike Thomas bought $248,066 worth of shares (10,000 units at $24.81), increasing direct ownership by 21% to 57,827 units (SEC Form 4)

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      5/30/24 4:34:01 PM ET
      $FTRE
      Medical Specialities
      Health Care

    Fortrea Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Russell Erin L

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      6/12/25 8:19:06 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Sanders Machelle

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      6/12/25 8:18:10 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Smith David Ross

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      6/12/25 8:17:01 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Pesicka Edward A

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      6/12/25 8:16:10 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Ray Amrit

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      6/12/25 8:15:03 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • Chief Operating Officer Morais Mark A. converted options into 11,007 shares and sold $13,052 worth of shares (3,130 units at $4.17), increasing direct ownership by 20% to 46,549 units (SEC Form 4)

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      6/4/25 5:44:48 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • Chief Financial Officer Mcconnell Jill G. sold $13,052 worth of shares (3,130 units at $4.17) and converted options into 11,007 shares, increasing direct ownership by 19% to 48,344 units (SEC Form 4)

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      6/4/25 5:43:38 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • General Counsel Hanson James S. converted options into 7,706 shares and sold $9,136 worth of shares (2,191 units at $4.17), increasing direct ownership by 58% to 14,981 units (SEC Form 4)

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      6/4/25 5:42:11 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • Director Smith David Ross converted options into 7,282 shares and covered exercise/tax liability with 2,185 shares, increasing direct ownership by 115% to 9,544 units (SEC Form 4)

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      5/16/25 4:51:56 PM ET
      $FTRE
      Medical Specialities
      Health Care
    • Director Pesicka Edward A converted options into 7,282 shares, increasing direct ownership by 115% to 13,636 units (SEC Form 4)

      4 - Fortrea Holdings Inc. (0001965040) (Issuer)

      5/16/25 4:49:48 PM ET
      $FTRE
      Medical Specialities
      Health Care